Merck KGaA Selects PRA’s Remote Patient Monitoring Platform for Human Growth Hormone Treatment System

 Merck KGaA Selects PRA’s Remote Patient Monitoring Platform for Human Growth Hormone Treatment System

Shots:

  • Merck KGaA selects PRA’s remote patient monitoring platform to work in combination with its HGH treatment system
  • PRA’s remote patient monitoring platform will support Merck’s KGH system including its growlink (mobile app) and easypod connect (HCP platform) to monitor patient adherence, review injection history, and share information about the progress of patients with GHD
  • The addition of a patient monitoring platform to HGH treatments better facilitates patient engagement, helps HCPs to make better use of patient visits, and ensures the treatment is taken regularly and at the right dosage, optimizing treatment outcome and driving payer confidence

Click here to­ read full press release/ article | Ref: Globe Newswire | Image: Glassdoor

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post